Skip to search formSkip to main contentSkip to account menu

Myleran

Known as: Myléran 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (1)

Busulfan
Busulfan 2 MG Oral Tablet [Myleran]MyelosanMylecytan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.
The comparative metabolism of the enantiomers of cyclo phosphamide and of the racemate has been studied in humans. Four patients… 
1972
1972
Studies on the cytotoxicity of Myleran and dimethyl Myleran.
Myleran and dimethyl Myleran (DMM) are two potentially bifunctional alkylating agents which might be expected to form cross-links… 
1966
1966
The periodic acid-Schiff reaction in neutrophil leukocytes in untreated and myleran-treated chronic myelocytic leukemia. A quantitative microspectrophotometric study.
Microspectrophotometric quantification of the periodic acid-Schiff (PAS) reaction has been performed in about 3,000 individual… 
Highly Cited
1961
Highly Cited
1961
A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.
Four patients who developed a clinical syndrome characterized by hyperpigmentation of the skin, weakness, fatigue, weight loss… 
1961
1961
On the mechanism of action of the alkylating agents. II. Effects of nitrogen mustard, Myleran, and x-radiation on nucleic acid biosynthesis.
The effects of nitrogen mustard, Myleran, and x-radiation on the incorporation of isotopic orotic acid, aspartic acid… 
Review
1961
Review
1961
Case Report: Leukemia and Pregnancy: Observation of a Case Treated with Busulfan (Myleran)
The case of a 28 year old woman with chronic myelocytic leukemia, who conceived while under treatment with busulfan, is reported… 
1958
1958
Treatment of polycythemia vera with busulfan (myleran).
Polycythemia vera was treated in 18 patients in whom the disease had existed for periods ranging from two months to 10 years… 
1956
1956
Myleran in pregnancy; report of a case.
Myleran (1,4-dimethanesulfonoxybutane) administered by mouth is generally considered the treatment of choice in chronic… 
1956
1956
Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia.
• Chronic granulocytic leukemia in 21 patients was treated with Myleran. Significant remissions for periods up to 48 months were… 
1955
1955
Cataracts produced in rats by 1, 4-dimethanesulfonoxybutane (myleran).
Haddow and Timmis,1in the course of preparation of a series of sulfonic acid compounds, found only the sulfonic acid esters… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)